Literature DB >> 10753036

Impaired glucose tolerance, Type II diabetes mellitus and carotid atherosclerosis: prospective results from the Bruneck Study.

E Bonora1, S Kiechl, F Oberhollenzer, G Egger, R C Bonadonna, M Muggeo, J Willeit.   

Abstract

AIMS/HYPOTHESIS: Cardiovascular disease is a well-known severe complication of impaired glucose tolerance and Type II (non-insulin-dependent) diabetes mellitus. The independent contribution of glucose intolerance to cardiovascular disease and the underlying pathogenic mechanisms are still, however, not clear.
METHODS: In this prospective population-based study, 826 subjects aged 40-79 years underwent high resolution duplex ultrasound examinations of carotid arteries and extensive clinical and laboratory screenings for potential vascular risk factors at baseline and 5 years later. The ultrasound protocol involved measurements of maximum axial diameter of atherosclerotic plaques, if any, in common and internal carotid arteries on both sides and enable differentiation of two main stages in carotid artery disease, termed early non-stenotic and advanced stenotic atherosclerosis. Intima-media thickness was assessed at the follow-up examination.
RESULTS: Type II diabetes and, to a lesser extent, impaired glucose tolerance were found to be statistically significant risk predictors of 5-year changes in carotid atherosclerosis. These associations were in part independent of other vascular risk factors typically clustering with glucose intolerance. Both impaired glucose tolerance and Type II diabetes mellitus were not independently related to early non-stenotic atherosclerosis. In contrast, Type II diabetes mellitus was the strongest single risk predictor of advanced stenotic atherosclerosis [odds ratio 5.0 (95% confidence intervals 2.3-11.1)] and impaired glucose tolerance was of relevance as well [odds ratio 2.8 (1.2-6.4)] (p < 0.001). CONCLUSION/
INTERPRETATION: Impaired glucose tolerance and, to a greater extent, Type II diabetes were strong independent predictors of advanced carotid atherosclerosis in our prospective population-based study.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10753036     DOI: 10.1007/s001250050024

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  28 in total

1.  Determination of nerve conduction abnormalities in patients with impaired glucose tolerance.

Authors:  Sevki Sahin; Sibel Karsidag; Sunay Ayalp; Ahmet Sengul; Onder Us; Kubilay Karsidag
Journal:  Neurol Sci       Date:  2009-05-15       Impact factor: 3.307

Review 2.  [Prevention of stroke].

Authors:  Stefan Kiechl; Otto Traindl
Journal:  Wien Med Wochenschr       Date:  2003

3.  Impaired hepatic insulin signalling in PON2-deficient mice: a novel role for the PON2/apoE axis on the macrophage inflammatory response.

Authors:  Noam Bourquard; Carey J Ng; Srinivasa T Reddy
Journal:  Biochem J       Date:  2011-05-15       Impact factor: 3.857

4.  Genetic association between eNOS gene polymorphisms and risk of carotid atherosclerosis : A meta-analysis.

Authors:  Yongheng Chen; Lin Chen; Qiliang Zhou
Journal:  Herz       Date:  2020-10-23       Impact factor: 1.443

5.  Lipid Profiles, Inflammatory Markers, and Insulin Therapy in Youth with Type 2 Diabetes.

Authors:  Lorraine E Levitt Katz; Fida Bacha; Samuel S Gidding; Ruth S Weinstock; Laure El Ghormli; Ingrid Libman; Kristen J Nadeau; Kristin Porter; Santica Marcovina
Journal:  J Pediatr       Date:  2018-02-02       Impact factor: 4.406

6.  Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus.

Authors:  David M Nathan; John Lachin; Patricia Cleary; Trevor Orchard; David J Brillon; Jye-Yu Backlund; Daniel H O'Leary; Saul Genuth
Journal:  N Engl J Med       Date:  2003-06-05       Impact factor: 91.245

7.  Carotid intima-media thickness and stiffness in relation to type 2 diabetes in Chinese.

Authors:  Yan-Ping Liu; Wei-Wei Zhan; Yi-Fei Zhang; Yu-Hong Chen; Yan-Yan Lin; Ying Zhu; Xin-Ping Ren; Xiao-Ying Li; Guang Ning
Journal:  Endocrine       Date:  2007-06       Impact factor: 3.633

8.  Carotid stiffness and microalbuminuria in patients with type 2 diabetes.

Authors:  Wei-Wei Zhan; Yu-Hong Chen; Yi-Fei Zhang; Ying Zhu; Yan-Yan Lin; Xin-Ping Ren; Xiao-Ying Li; Yan-Ping Liu
Journal:  Endocrine       Date:  2009-04-15       Impact factor: 3.633

Review 9.  Should postprandial hyperglycaemia in prediabetic and type 2 diabetic patients be treated?

Authors:  Guillaume Charpentier; Jean-Pierre Riveline; Dured Dardari; Michel Varroud-Vial
Journal:  Drugs       Date:  2006       Impact factor: 9.546

10.  Neuropathy associated with prediabetes: what is new in 2007?

Authors:  J Rob Singleton; A Gordon Smith
Journal:  Curr Diab Rep       Date:  2007-12       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.